Impactiviti Daily 022510

***** TODAY’S NEWS If Shire were in Olympics, they’d now be on the speed skating short track – Shire has been boosted by the news that regulators in the USA will give a quicker review to the firm’s Fabry disease drug Replagal. The company has received fast-track designation from the US Food and Drug Admininstration [...]

Read Full Post »

Novartis, CF, and Social Media

Pharmaceutical company Novartis has been experimenting with social media technologies, which is something I am entirely pleased about – every company in this industry that makes SocMed efforts should be applauded for doing so, even if some early applications are limited, tentative, and less than fully “social.” Pharma is a highly-regulated industry, and what looks [...]

Read Full Post »

Impactiviti Daily 022410

***** TODAY’S NEWS Why one hospital is restricting drug sales reps (news clip). Interesting perspectives on sampling. Possible heart problem with HIV drug combo – The U.S. Food and Drug Administration said on Tuesday that HIV drugs Invirase and Norvir might lead to an abnormal heart rhythm when used in combination, according to preliminary data [...]

Read Full Post »

Impactiviti Daily 022310

***** TODAY’S NEWS Big approval news for Gilead Sciences – Gilead Sciences Inc., the world’s largest maker of HIV treatments, won U.S. approval of an inhaled antibiotic for lung infections in cystic fibrosis patients. The Food and Drug Administration cleared sales of the medicine, given the brand name Cayston, the company said today in a [...]

Read Full Post »

Impactiviti Daily 022210

TODAY’S NEWS Big news for Novartis on two fronts – Novartis has received a couple of pieces of good news from regulators in the USA this morning who have approved its meningococcal vaccine Menveo and granted a priority review for the Swiss major’s investigational oral treatment for multiple sclerosis fingolimod…more Avandia – the bad news [...]

Read Full Post »

Pharma eMarketing Round-up Feb 19, 2010

From Sally Church – Online video viewing accelerates – where is Pharma? Useful stats and a good question. And from the recent ePharma Summit – who is doing it best so far? (from Kevin Nalty and Clare O’Brien). PLUS – a free e-book, just made available by Kru Research – Using YouTube for e-Patient Communications. [...]

Read Full Post »

Impactiviti Daily 021910

TODAY’S NEWS Big news on the leukemia front: Novartis‘ Tasigna gets priority FDA review for newly-diagnosed patients; and Roche/Genentech‘s Rituxan approved for CLL. A quarter of new prescriptions go unfilled. Statins: cardiovascular benefits far outweigh the diabetes risks – Statin drugs raise the risk of diabetes significantly, but the danger appeared puny compared with their [...]

Read Full Post »

Impactiviti Daily 021610

Looking for a new job – or, the best place to post your pharma job openings? Check out the new “social search” Impactiviti Job Board – designed to give you maximum reach AND the most targeted audience available! TODAY’S NEWS On a Tuesday after a long weekend, I have looked in vain for interesting news [...]

Read Full Post »

Impactiviti Daily 021210

Review of this week’s snow-impacted ePharma Summit conference is now up on the blog! TODAY’S NEWS Benicar for kiddies – Olmesartan medoxomil (Benicar), approved in 2002 to treat high blood pressure in adults, has been sanctioned by the U.S. Food and Drug Administration to treat the same condition in children aged 6 to 16, drug [...]

Read Full Post »

ePharma Summit 2010 Re-cap

This week, I was privileged to take part in the 9th annual ePharma Summit, put on by the folks at IIRUSA. This event had the misfortune to be located in Philadelphia during the Smomaggeden III incident, so a number of folks (including me) felt compelled to bail out before the worst of the storm hit [...]

Read Full Post »